We have HCT116 and HepG2 cancer cell line in our lab, in which we are planning to use either one of them. The research article below suggests to use Caco-2 cell line instead of HepG2. I would like to know what are disadvantages of using HepG2 cell line with respect to cellular antioxidant studies.
Can we use HCT116 cancer cell line for the cellular antioxidant study?
Help appreciated!! Thanks
Article Modification of the Cellular Antioxidant Activity (CAA) Assa...
Depending on your main objective, you can use any of these cell lines. As you may already know, HCT116 and Caco-2 are colon cancer cell lines while HepG2 is a liver cancer cell.
While many cell lines response differently, I suggest to use all of them and even other lines from other organs, because you are trying to show the antioxidant effect of your plant extract.
You can focus on a specific disease (such as colon cancer) and work on HCT-116 and Caco-2. Or just use large spectrum.
I have worked on both cell-lines (HCT-116 and caco-2) and I can say you can you use any of them, I say again depending on your aim. The options are unlimited.
I had some difficulties to work with HCT116 for the study of oxidative stress, not in the growth and treatment, but in the application of my protocols for the measures because my cellular layers, fixed or not, were peeling off.
Thank you for the feedback Mr. Hichem. Since the elimination of antioxidant compound in liver is one of the major concern, can we say that liver cancer cell line is not a good model for antioxidant activity evaluation? If we take intestinal barrier as a important issue in this case, can we say that colon cancer cell line is more superior compared to Hepg2?
I think that the human hepatocellular carcinoma HepG2 usually used to evaluate the protective action of plant extract against ROS-induced oxidatative stress.